Rocket One RKTO
NASDAQ RKTO
$0.67 -0.03 (-4.40%)
At close: Sep 9, 2026 · 4:00 PM EDT

Rocket One (RKTO) Change in Accured Expenses (2018 - 2026)

Rocket One's (RKTO) quarterly Change in Accured Expenses came in at -$48858.0 in Q2 2026, up 88.97% year-over-year from -$25854.3 in Q2 2025, and down 239.15% quarter-over-quarter from -$14406.0 in Q1 2026.

Analysis

Rocket One (RKTO) Change in Accured Expenses (2018 - 2026) Analysis & Trends

Rocket One has disclosed Change in Accured Expenses across 6 years of filings, most recently posting -$48858.0 for Q2 2026.

  • In Q2 2026, Change in Accured Expenses rose 88.97% year-over-year to -$48858.0; the TTM figure through Jun 2026 stood at $1.0 million (up 438.4% YoY), while the FY2025 annual figure was $644166.0, up 320.99% from the prior year.
  • Change in Accured Expenses came in at -$48858.0 for Q2 2026 at Rocket One, down from -$14406.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $655781.0 in Q3 2025 to a low of -$1.2 million in Q4 2023.
  • Average Change in Accured Expenses over 4 years is -$24814.2, with a median of $4599.5 recorded in 2024.
  • The largest YoY upside for Change in Accured Expenses was 1797.53% in 2025 against a maximum downside of 1201.14% in 2025.
  • Over 4 years, Change in Accured Expenses stood at -$1.2 million in 2023, then jumped by 101.91% to $23605.0 in 2024, then jumped by 1797.53% to $447912.0 in 2025, then plunged by 110.91% to -$48858.0 in 2026.
  • Per Business Quant data, the three most recent Change in Accured Expenses figures were -$48858.0 in Q2 2026, -$14406.0 in Q1 2026, and $447912.0 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn 852.00 Mn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn 338.00 Mn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 222.50 Mn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 492.70 Mn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn -
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn 11.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn 61.62 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn -49.70 Mn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn -13.91 Mn
10 Rocket One 13.86 Mn 5.97 Mn - -48,858.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -48,858.00
Mar 31, 2026 -14,406.00
Dec 31, 2025 447,912.00
Sep 30, 2025 655,781.00
Jun 30, 2025 -443,132.00
Mar 31, 2025 -16,395.00
Dec 31, 2024 23,605.00
Sep 30, 2024 128,470.00
Jun 30, 2024 40,243.00
Mar 31, 2024 -39,305.00
Dec 31, 2023 -1.24 Mn
Sep 30, 2023 207,182.00
Jun 30, 2019 9,795.00
Mar 31, 2019 17,332.00
Dec 31, 2018 208,213.00